Product Details

The Role of Biomarkers in AKI Risk Assessment

Experience the educational content from the Society of Critical Care Medicine's (SCCM) 2016 Congress session, The Role of Biomarkers in Acute Kidney Injury Risk Assessment, from the comfort of your home or office. During this session, expert faculty discuss the pathophysiology, etiology and epidemiology of acute kidney injury (AKI). Risk stratification scores, first-generation AKI markers and new markers of AKI and risk assessment are examined. This product includes videos containing slide presentations and synchronized speaker audio of the session, as well as posttests.

Physicians, nurses and pharmacists are eligible to receive 1.5 hours of continuing education credit. This opportunity is available through April 2017.

Supported by an educational grant from Astute Medical, Inc.
Additional Information:

Learning Objectives

  • Describe the pathophysiology, etiology and epidemiology of AKI
  • Review the RIFLE, AKIN, and KDIGO AKI definitions and classifications
  • Define the two new biomarkers for AKI
  • Explain the role of biomarkers in assessing AKI


Acute Kidney Injury: Pathophysiology, Etiology and Epidemiology
Sean M. Bagshaw, MD, MSc

Risk Stratification Scores and First Generation AKI Markers: NGAL, KIM-1, IL-18
Jay L. Koyner, MD

New Markers of AKI and Risk Assessment: TIMP2, IGFBP7
Azra Bihorac, MD, MS, FCCM

View System Requirements.

Product Code:
↑/↓ Full Details

Product Reviews
Log in now to rate/review this product!
5 star
4 star
3 star
2 star
1 star
Average Rating
(1 review)
perfect May 23, 2016 2:40 PM
By: Ricardo A. Tovar, Sr., MD


Was this review helpful?  Log in now to comment on this review!
0 item(s) ($0.00)
Product Categories
Recently Viewed
© Copyright Society of Critical Care Medicine. All Rights Reserved.
Contact Us | Privacy Statement | Terms and Conditions
Headquarters | 500 Midway Drive, Mount Prospect, IL 60056 USA
Phone: +1 847 827-6869 | Fax: +1 847 827-6886 | Email: